Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 1 (2017) BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS Abstract  similar documents
E. A. Pyadushkina
"... Aims of the study: to assess health care costs of the use of biological agents (vedolizumab ..."
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis Abstract  similar documents
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova
"... среднетяжелой и тяжелой степени на основе результатов сетевого метаанализа рандомизированных клинических ..."
 
Vol 16, No 1 (2023) Efficiency of Levilimab in patients with moderate and severe COVID-19 Abstract  similar documents
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov
"... лечении пациентов со среднетяжелым и тяжелым течением COVID-19 на основании данных реальной клинической ..."
 
Vol 8, No 2 (2015) CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA Abstract  similar documents
Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova
"... аллергенспецифической иммунотерапии (АСИТ) у пациентов с аллергической бронхиальной астмой легкого и среднетяжелого ..."
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation Abstract  similar documents
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev
"... , меполизумаб и реслизумаб при лечении больных неконтролируемой среднетяжелой и тяжелой атопической бронхиальной ..."
 
Vol 15, No 1 (2022) Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update Abstract  similar documents
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva
"... опубликованных результатов РКИ, изучающих эффективность терапии взрослых пациентов со среднетяжелым и тяжелым ..."
 
Vol 13, No 2 (2020) Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? Abstract  similar documents
A. M. Lila, I. Yu. Torshin, O. A. Gromova
"... биологические эффекты фактора некроза опухолей-a (ФНО-a). Избыточная активность NF-kB также стимулирует и ..."
 
Vol 16, No 2 (2023) Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy Abstract  similar documents
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina
"... комбинациями в сравнении со стандартной терапией у пациентов с легким или среднетяжелым течением COVID-19 для ..."
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract  similar documents
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
"... diagnosis-related group in terms of bronchial asthma (BA) and inflammatory bowel disease (IBD) - Crohn ..."
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
"... среднетяжелых и тяжелых пациентов с COVID-19 и признаками ЦШ. Эта группа препаратов указывается как основная для ..."
 
Vol 10, No 2 (2017) COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD Abstract  similar documents
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
"... среднетяжелым течением (ОФВ1 ≥50%) не является достаточно эффективной, использование ЛП вилантерол + умеклидиния ..."
 
Vol 10, No 4 (2017) PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... среднетяжелой гемофилии А является профилактическая терапия VIII фактором свертывания. Расширение практики ..."
 
1 - 12 of 12 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)